Actively Recruiting

Phase Not Applicable
Age: 75Years +
All Genders
NCT06634290

Influence of Cemented Cephalic Augmentation on the Outcome of Intramedullary Nailing in Pertrochanteric Hip Fractures

Led by Diego Matías Domínguez Prado · Updated on 2024-10-09

314

Participants Needed

6

Research Sites

100 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to learn if small modifications in the surgical technique for the treatment of some kind of hip fractures, improve the result of the surgery. This small modification includes the addition of surgical bone cement to part of the intramedullary nail used in the surgery, to find out if it provides more stability to the construct and represents an improvement in the surgery result. The main question it aims to answer is: Does the addition of bone cement produces a decrease in complications related to mechanical failure of the implant used in the surgery and a decrease in the need for re-operation? Researchers will compare adding this bone cement to the standard surgical technique without it. Patients will: * Be randomly assigned to a group that will have surgery following standard protocol or to a group that will have surgery following standard protocol but adding bone cement to the construct. * Receive standard care for these fractures during hospitalization and posterior follow-up checkups for a year.

CONDITIONS

Official Title

Influence of Cemented Cephalic Augmentation on the Outcome of Intramedullary Nailing in Pertrochanteric Hip Fractures

Who Can Participate

Age: 75Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 75 years of age or older.
  • Diagnosis with a pertrochanteric fragility fracture.
  • Informed consent for participation in the study.
Not Eligible

You will not qualify if you...

  • Not meeting the inclusion criteria described above.
  • Refusal of the patient or his/her legal representative to participate in the study.
  • Diagnosis with hip fracture of subtypes other than 31A1, 31A2, 31A3 and 31B3 of AO-OTA classification.
  • Bilateral hip fractures in the same episode.
  • Suffering from previous medical pathologies or comorbidities that contraindicate surgical intervention and indicate conservative management of the fracture.
  • Performing a surgical technique different from intramedullary nailing or using a surgical implant different from that used in the present study.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 6 locations

1

Hospital de Monforte de Lemos

Monforte de Lemos, Lugo, Spain, 27400

Actively Recruiting

2

Hospital de Verin

Verín, Ourense, Spain, 32600

Actively Recruiting

3

Complexo Hospitalario Universitario de Vigo

Vigo, Pontevedra, Spain, 36312

Actively Recruiting

4

Hospital do Salnes

Vilagarcía de Arousa, Pontevedra, Spain, 36619

Actively Recruiting

5

Complexo Hospitalario Universitario de Ourense

Ourense, Spain, 32005

Actively Recruiting

6

Complexo Hospitalario Pontevedra

Pontevedra, Spain, 36071

Actively Recruiting

Loading map...

Research Team

D

Diego Matias Dominguez Prado, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here